FDA Adverse Event
Injury
Summary report: N
ACTASEPT WITH 2% CHG ANTISEPTIC SOLUTION
MDR report key: 1695603
·
Received May 18, 2010
Report
- Report Number
- MW5015988
- Event Type
- Injury
- Date Received
- May 18, 2010
- Manufacturer
- MEDICAL ACTION INDUSTRIES, INC
- Product Code
- LRS
- Product Problem
- Yes
- Report Source
- Voluntary report
- Reporter Location
- OH, US
- Reporter Occupation
- RISK MANAGER
Narratives
Description of Event or Problem · 1
WE HAVE NOTED IN OUR CV UNIT THAT PTS ARE DEVELOPING SKIN BREAKDOWN, REDNESS AND BLISTERING UNDER THE TEGADERM. APPROXIMATELY 10 CASES. THE COMPANY HAS BEEN CALLED AND WE HAVE SUSPENDED USE IN OUR CV DEPT. DIAGNOSIS OR REASON FOR USE: STERILE DRESSING FOR CENTRAL LINES.
Devices
| Seq | Brand | Generic | Product Code | Manufacturer | Model | Lot | UDI-DI |
|---|---|---|---|---|---|---|---|
| 1 | ACTASEPT WITH 2% CHG ANTISEPTIC SOLUTION | ANTISEPTIC SOLUTION | LRS | MEDICAL ACTION INDUSTRIES, INC | 081011 | ||
| 2 | 3M TEGADERM DRESSING | DRESSING | NAD | * |
Patients
| Seq | Age | Sex | Outcome | Treatment |
|---|---|---|---|---|
| 1 | Disability |